51 compounds and their % Absorbed values have been provided in the paper. For some compounds the values have either not been given or indicated as irregular/poor/erratic/rapidly metabolized. THe datasets are available from QSAR World: http://www.qsarworld.com/qsar-datasets-yazdanian.php
Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, and Cooper I.
Rate-limited Steps of Human Oral Absorption and QSAR Studies, Pharm Res., 2002, 19(10), 1446-57
G. F. Fabiola, V. Pattabhi, S. G. Manjunatha, G. V. Rao and K. Nagarajan.
4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-Dioxide, Acta Cryst. (1998). C54, 2001-2003Â Â Â Â
Dattatray T. Modhave, Tarun Handa, Ravi P. Shah and Saranjit Singh.
Successful characterization of degradation products of drugs using LC-MS tools: Application to piroxicam and meloxicam, Anal. Methods, 2011, 3, 2864.
Cláudia Nunes, Gerald Brezesinski, José L. F. C. Lima, Salette Reis and Marlene Lúcio.
Effects of non-steroidal anti-inflammatory drugs on the structure of lipid bilayers: therapeutical aspects, Soft Matter, 2011, 7, 3002.
Sandra Defazio and Renzo Cini.
Synthesis, X-ray structure and molecular modelling analysis of cobalt(ii), nickel(ii), zinc(ii) and cadmium(ii) complexes of the widely used anti-inflammatory drug meloxicam, Dalton Trans., 2002, 0, 1888.
Selvi Dev, Jeremiah Toster, S. Vadhan Prasanna, Melinda Fitzgerald, K. Swaminathan Iyer and Colin L. Raston.
Suppressing regrowth of microfluidic generated drug nanocrystals using polyelectrolyte coatings, RSC Advances, 2013, 3, 695.